Arterial hypertension: importance of individual drugs selection and place of angiotensin-converting enzyme inhibitors in the treatment
- Authors: Martynov AI1, Martinov AI1
-
Affiliations:
- Issue: No 15 (2009)
- Pages: 83-87
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278043
- ID: 278043
Cite item
Full Text
Abstract
The paper presents the problem of treatment of hypertension according to patient clinical characteristics and risk factors for cardiovascular complications. Given to endothelial dysfunction in patients with arterial hypertension, drugs of choice currently are angiotensin converting enzyme inhibitors with significant antihypertensive and organoprotective action. By the way to achieve the target level of blood pressure, combinations of antihypertensive agents is often used, in which different classes of drugs are used to increase the additivity of action and reduce the severity of side effects.
References
- Собрание законодательства Российской Федерации. 2001. № 31. С. 3280.
- Диагностика и лечение артериальной гипертензии. Рекомендации Российского медицинского общества по артериальной гипертензии и Всероссийского научного общества кардиологов. М., 2008. 32 с.
- Федеративное руководство по использованию лекарственных средств. Выпуск IX. М., 2008. С. 129-141.
- Савенков М.П. и др. Антигипеpтензивный эффект эналапpила и лизинопpила пpи пpименении нестеpоидных пpотивовоспалительных пpепаpатов // Терапевтический архив. 2001. № 9. С. 27-31.
- GISSI-3 Investigators. GISSI-3:Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:1115-22.
- Leonetti G, Cuspidi C. Choosing the right ACE inhibitor: a guide to selection. Drugs 1995;49:516-35.
- Latini R, et al. Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial. Heart Dis 2000;2(3):185-90.
- TROPHY study. Hypertension 1997;30(part 1):140-45.
- Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID study group. Lancet 1997;349:1787-92.
- Masden JS, et al. Eur J Hypertension 1998.
- Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart. ATLAS Study Group. Circulation 1999;100:2312.
- http://www.pharmateca.ru/cgi-bin/statyi.pl?sid=2410&mid=1085056570&magid=179
Supplementary files
